Cargando…

Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors

There is an unmet need for novel biomarkers to diagnose and monitor patients with neuroendocrine neoplasms. The EXPLAIN study explores a multi‐plasma protein and supervised machine learning strategy to improve the diagnosis of pancreatic neuroendocrine tumors (PanNET) and differentiate them from sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiis‐Evensen, Espen, Kjellman, Magnus, Knigge, Ulrich, Gronbaek, Henning, Schalin‐Jäntti, Camilla, Welin, Staffan, Sorbye, Halfdan, del Pilar Schneider, Maria, Belusa, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Translational and Clinical Neuroendocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787472/ https://www.ncbi.nlm.nih.gov/pubmed/35829662 http://dx.doi.org/10.1111/jne.13176

Ejemplares similares

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
por: Papantoniou, Dimitrios, et al.
Publicado: (2023)

Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours
por: Sorbye, Halfdan, et al.
Publicado: (2020)

Volumetric parameters from [ (18)F]FDG PET/CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms
por: Langen Stokmo, Henning, et al.
Publicado: (2022)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
por: Ali, Abir Salwa, et al.
Publicado: (2018)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
por: Dumanski, Jan P, et al.
Publicado: (2017)

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
por: Ali, Abir Salwa, et al.
Publicado: (2017)

Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022)

LBMON138 Leg Tumeo: Is It Neuroendocrine Tumor?
por: Priyadarshini, Shista, et al.
Publicado: (2022)

The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
por: Cives, Mauro, et al.
Publicado: (2022)

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
por: Becker, Anna, et al.
Publicado: (2021)

Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
por: Gedde-Dahl, Merete, et al.
Publicado: (2013)

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease
por: Thiis-Evensen, Espen, et al.
Publicado: (2020)

Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors
por: Kjaer, Andreas, et al.
Publicado: (2015)

THU083 Disulfiram Mediated Anti-tumor Effect In Pituitary Neuroendocrine Tumors By Inducing Cuproptosis
por: Huang, Ning, et al.
Publicado: (2023)

Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
por: Ramage, John K., et al.
Publicado: (2022)

Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission
por: Juhlin, Carl Christofer, et al.
Publicado: (2020)

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation
por: Varghese, Diana Grace, et al.
Publicado: (2022)

THU084 Corticotroph Tumor Type Influences Clinical Presentation In Patients With Nonfunctioning Pituitary Neuroendocrine Tumors
por: Al-Shamkhi, Nasrin, et al.
Publicado: (2023)

Acromegaly in a Young Women With Pituitary Hyperplasia Secondary to a Neuroendocrine Tumor
por: Bano, Gul
Publicado: (2021)

ODP300 c-MET expression in MEN1-associated neuroendocrine tumors
por: Ghosh, Raisa, et al.
Publicado: (2022)

ODP315 Hypoglycemia: Neuroendocrine Tumor of the Pancreas with Liver Metastasis and Transformation to Insulinoma
por: Ali, Basim, et al.
Publicado: (2022)

PMON38 Severe Refractory Hypoglycemia in a Patient with Metastatic Neuroendocrine Tumor
por: Polis, Sarah, et al.
Publicado: (2022)

FRI362 A Rare Case Of Coexisting Pancreatic Neuroendocrine Tumor And Nesidioblastosis
por: Mon, Nandar, et al.
Publicado: (2023)

PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)

Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta‐analysis
por: Kaçmaz, Enes, et al.
Publicado: (2021)

SAT-314 Pituitary and Neuroendocrine Tumors Exhibit Distinct Transcriptomes on Single Cell RNA Sequencing
por: Zhang, Dongyun, et al.
Publicado: (2020)

ODP303 Cushing's Syndrome Due to Ectopic Adrenocorticotropic Hormone-Secreting Metastatic Neuroendocrine Tumor
por: Cipriani, Allison, et al.
Publicado: (2022)

FRI308 A Rare Case Of Plurimorphous Plurihormonal Pituitary Neuroendocrine Tumor With LH Hypersecretion
por: Jeevananthan, Athavi, et al.
Publicado: (2023)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas
por: Dasari, Arvind, et al.
Publicado: (2022)

ODP602 A Rare Case of Nonfunctional Metastatic Pancreatic Neuroendocrine Tumor Transformation into an Insulin-secreting Tumor: A Management Dilemma
por: Azmath, Misbath, et al.
Publicado: (2022)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors
por: Bergestuen, Deidi Strickland, et al.
Publicado: (2010)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_814n5hm5k2n9mvsktm52c2ds2r